NYMX Nymox Pharmaceutical Corp

Nymox Pharmaceutical Corp, along with its subsidiaries, is a biopharmaceutical corporation, engaged in research and development of drugs and diagnostic products for aging population. Its product portfolio consists of Nic alert and Tobac alert.

$1.74
As of 06/11/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Canada
Country of incorporation:  Bahamas
IPO date:  02/11/2013
Outstanding shares:  82,380,875
Average volume:  519,899
Market cap:   $148,285,575
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    P73398102
ISIN:        BSP733981026
Sedol:      BYTR3Q6
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   62.14
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy